PortfoliosLab logo
NVS vs. O
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between NVS and O is 0.45, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.


Performance

NVS vs. O - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Novartis AG (NVS) and Realty Income Corporation (O). The values are adjusted to include any dividend payments, if applicable.

1,000.00%1,500.00%2,000.00%December2025FebruaryMarchAprilMay
794.88%
2,039.31%
NVS
O

Key characteristics

Sharpe Ratio

NVS:

1.04

O:

0.63

Sortino Ratio

NVS:

1.47

O:

0.98

Omega Ratio

NVS:

1.21

O:

1.12

Calmar Ratio

NVS:

1.01

O:

0.47

Martin Ratio

NVS:

2.19

O:

1.27

Ulcer Index

NVS:

9.22%

O:

9.17%

Daily Std Dev

NVS:

19.43%

O:

18.44%

Max Drawdown

NVS:

-41.72%

O:

-48.45%

Current Drawdown

NVS:

-3.09%

O:

-11.71%

Fundamentals

Market Cap

NVS:

$225.73B

O:

$50.80B

EPS

NVS:

$6.38

O:

$0.98

PE Ratio

NVS:

17.91

O:

58.12

PEG Ratio

NVS:

1.36

O:

5.52

PS Ratio

NVS:

4.24

O:

9.62

PB Ratio

NVS:

5.88

O:

1.31

Total Revenue (TTM)

NVS:

$52.86B

O:

$5.40B

Gross Profit (TTM)

NVS:

$39.86B

O:

$4.60B

EBITDA (TTM)

NVS:

$21.88B

O:

$4.13B

Returns By Period

In the year-to-date period, NVS achieves a 20.39% return, which is significantly higher than O's 9.18% return. Over the past 10 years, NVS has underperformed O with an annualized return of 6.90%, while O has yielded a comparatively higher 7.38% annualized return.


NVS

YTD

20.39%

1M

6.83%

6M

6.00%

1Y

20.44%

5Y*

11.44%

10Y*

6.90%

O

YTD

9.18%

1M

3.73%

6M

-1.20%

1Y

8.95%

5Y*

8.18%

10Y*

7.38%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

NVS vs. O — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

NVS
The Risk-Adjusted Performance Rank of NVS is 7878
Overall Rank
The Sharpe Ratio Rank of NVS is 8484
Sharpe Ratio Rank
The Sortino Ratio Rank of NVS is 7676
Sortino Ratio Rank
The Omega Ratio Rank of NVS is 7676
Omega Ratio Rank
The Calmar Ratio Rank of NVS is 8383
Calmar Ratio Rank
The Martin Ratio Rank of NVS is 7373
Martin Ratio Rank

O
The Risk-Adjusted Performance Rank of O is 6767
Overall Rank
The Sharpe Ratio Rank of O is 7373
Sharpe Ratio Rank
The Sortino Ratio Rank of O is 6363
Sortino Ratio Rank
The Omega Ratio Rank of O is 6161
Omega Ratio Rank
The Calmar Ratio Rank of O is 7070
Calmar Ratio Rank
The Martin Ratio Rank of O is 6666
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

NVS vs. O - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Novartis AG (NVS) and Realty Income Corporation (O). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


The current NVS Sharpe Ratio is 1.04, which is higher than the O Sharpe Ratio of 0.63. The chart below compares the historical Sharpe Ratios of NVS and O, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-0.500.000.501.00December2025FebruaryMarchAprilMay
1.04
0.63
NVS
O

Dividends

NVS vs. O - Dividend Comparison

NVS's dividend yield for the trailing twelve months is around 3.53%, less than O's 5.58% yield.


TTM20242023202220212020201920182017201620152014
NVS
Novartis AG
3.53%3.84%3.44%3.91%4.08%3.40%2.87%3.72%3.50%4.06%3.51%3.14%
O
Realty Income Corporation
5.58%5.37%5.33%4.68%6.95%4.65%3.69%4.19%4.45%4.19%4.42%4.59%

Drawdowns

NVS vs. O - Drawdown Comparison

The maximum NVS drawdown since its inception was -41.72%, smaller than the maximum O drawdown of -48.45%. Use the drawdown chart below to compare losses from any high point for NVS and O. For additional features, visit the drawdowns tool.


-20.00%-15.00%-10.00%-5.00%December2025FebruaryMarchAprilMay
-3.09%
-11.71%
NVS
O

Volatility

NVS vs. O - Volatility Comparison

Novartis AG (NVS) has a higher volatility of 9.35% compared to Realty Income Corporation (O) at 7.91%. This indicates that NVS's price experiences larger fluctuations and is considered to be riskier than O based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


4.00%5.00%6.00%7.00%8.00%9.00%10.00%December2025FebruaryMarchAprilMay
9.35%
7.91%
NVS
O

Financials

NVS vs. O - Financials Comparison

This section allows you to compare key financial metrics between Novartis AG and Realty Income Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.002.00B4.00B6.00B8.00B10.00B12.00B14.00B20212022202320242025
13.62B
1.38B
(NVS) Total Revenue
(O) Total Revenue
Values in USD except per share items

NVS vs. O - Profitability Comparison

The chart below illustrates the profitability comparison between Novartis AG and Realty Income Corporation over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

50.0%60.0%70.0%80.0%90.0%100.0%20212022202320242025
76.3%
100.0%
(NVS) Gross Margin
(O) Gross Margin
NVS - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Novartis AG reported a gross profit of 10.39B and revenue of 13.62B. Therefore, the gross margin over that period was 76.3%.

O - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Realty Income Corporation reported a gross profit of 1.38B and revenue of 1.38B. Therefore, the gross margin over that period was 100.0%.

NVS - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Novartis AG reported an operating income of 4.66B and revenue of 13.62B, resulting in an operating margin of 34.2%.

O - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Realty Income Corporation reported an operating income of 1.34B and revenue of 1.38B, resulting in an operating margin of 96.8%.

NVS - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Novartis AG reported a net income of 3.61B and revenue of 13.62B, resulting in a net margin of 26.5%.

O - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Realty Income Corporation reported a net income of 249.82M and revenue of 1.38B, resulting in a net margin of 18.1%.